Current Treatment Methods for Charcot-Marie-Tooth Diseases.

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Charcot-Marie-Tooth (CMT) is the most prevalent inherited neuromuscular disorder, characterized by significant genetic heterogeneity and varied clinical presentations.
• Advances in molecular biology and gene sequencing have elucidated diverse genetic mechanisms underlying CMT over the last three decades.
• Current management for CMT focuses on symptom amelioration through rehabilitation, orthotics, and surgery, as no definitive cure exists.

Purpose of the Study:

• To review the pathogenic mechanisms of various Charcot-Marie-Tooth (CMT) subtypes.
• To discuss current and emerging therapeutic strategies for CMT.
• To highlight recent advancements in treatment target discovery for CMT.

Main Methods:

• Literature review of studies on Charcot-Marie-Tooth (CMT) disease.
• Analysis of genetic mechanisms and molecular pathways implicated in CMT.
• Examination of therapeutic investigations, including drug treatments and gene therapies.

Main Results:

• Identification of diverse molecular genetic mechanisms contributing to CMT subtypes.
• Progress in reclassifying CMT based on genetic findings.
• Emergence of novel therapeutic targets and approaches, with gene therapies showing promise.

Conclusions:

• Understanding CMT's genetic basis is crucial for developing effective treatments.
• Gene therapies represent a promising frontier for treating CMT, with some already in clinical trials.
• Continued research into pathogenic mechanisms and therapeutic interventions is vital for advancing CMT care.